CAS: 2162962-69-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CU-CPT-9b REF: AN-AG01EOJWCAS: 2162962-69-6 | 97% | 41.00 €~465.00 € | Fri 03 May 24 |
 | CU-CPT9b REF: TM-T7302CAS: 2162962-69-6 | 98% | 55.00 €~732.00 € | Fri 10 May 24 |
 | CU-CPT9b REF: 3D-MLD96269CAS: 2162962-69-6 | Min. 95% | To inquire | Fri 14 Jun 24 |
Ref: AN-AG01EOJW
| 1mg | 41.00 € | |
| 5mg | 64.00 € | |
| 10mg | 76.00 € | |
| 25mg | 103.00 € | |
| 50mg | 172.00 € | |
| 100mg | 207.00 € | |
| 250mg | 465.00 € |
Estimated delivery in United States, on Friday 3 May 2024
CU-CPT9b
CAS:2162962-69-6
CU-CPT9b (TLR8-specific antagonist 1) is an antagonist of toll-like receptor 8 (TLR8; Kd = 21 …
Formula:
C16H13NO2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
251.28
Ref: TM-T7302
| 1mg | 55.00 € | |
| 2mg | 80.00 € | |
| 5mg | 118.00 € | |
| 10mg | 185.00 € | |
| 25mg | 343.00 € | |
| 50mg | 522.00 € | |
| 100mg | 732.00 € | |
| 1ml*10 (DMSO) | 128.00 € |
Estimated delivery in United States, on Friday 10 May 2024
CU-CPT9b
CAS:2162962-69-6
CU-CPT9b is a potent compound that has been shown to have clinical relevance in the …
Formula:
C16H13NO2
Purity:
Min. 95%
Molecular weight:
251.28 g/mol
Ref: 3D-MLD96269
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 14 Jun 2024
